Therapeutics

In recognition of Cataract Awareness Month.

Lens option can correct for surgically induced astigmatism or an inaccurate position.

Bi-sign design compensates for aberrations resulting from misalignment.

Mark Packer, MD, offers personal insight in honor of Cataract Awareness Month.

Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.

Therapeutic choices beneficial for patients may be available in 1 to 3 years.

Investigators examine the demographic, refractive, PRO data measure.

Patients are serious about procedure and ready to move forward.

Investigators find treatment is an option for treating open-angle glaucoma.

Novel technique provides another option for normal and irregular corneas.

An alternative to drops, the option provides consistent therapeutic levels.

Refractive surgery for treating myopia is linked to low rates of regression, enhancement.

Several hundred genes are associated with congenital forms.

Sublingual troche sedation represents attractive anesthesia option for specific subset of patients with cataracts.

New option may prove to be a solution for cataract cases with unusual corneas.

One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S.

Patients show impressive proptosis and diplopia responses to teprotumumab.

Cataract surgeons must consider medication history as part of preoperative evaluation.

Investigators find options could prove to be alternatives to surgical management.

Phakic lenses are proving to be excellent additions to refractive practices.

Physician pioneers technique offering higher perspective in surgery, outcomes.

With intraoperative sustained release steroids, ophthalmologists can eliminate the gambles of patient adherence.

Study supports preoperative ocular surface optimization with artificial tears.

Change can prove to benefit individuals with diabetes, other comorbidities.